Amir Ahmadi

Search results

• Elucid Names Dr. Amir Ahmadi as a Chief Scientific Advisor

  Ahmadi, A.

  27/03/25

  1 item of Media coverage

  Press/Media

• Elucid Adds Clinical and Commercial Leadership Ahead of PlaqueIQ™ Launch

  Ahmadi, A.

  3/03/25

  5 items of Media coverage

  Press/Media

• Elucid Adds Clinical and Commercial Leadership Ahead of PlaqueIQ™ Launch Financial March 3, 2025

  Ahmadi, A.

  3/03/25

  3 items of Media coverage

  Press/Media

• Elucid names new execs ahead of PlaqueIQ launch

  Ahmadi, A.

  3/03/25

  1 item of Media coverage

  Press/Media

• Elucid Receives 510(k) Clearance of PlaqueIQ Image Analysis Software

  Ahmadi, A.

  4/10/24

  1 item of Media coverage

  Press/Media

• Elucid’s PlaqueIQ Image Analysis Software Receives FDA Clearance

  Ahmadi, A.

  1/10/24 → 2/10/24

  3 items of Media coverage

  Press/Media

• FDA Clears Software for Enhancing CCTA Assessment of Atherosclerosis

  Ahmadi, A.

  1/10/24

  1 item of Media coverage

  Press/Media

• Elucid Receives U.S. 510(k) Clearance of PlaqueIQ™ Image Analysis Software to Aid Cardiovascular Disease Assessment

  Ahmadi, A.

  1/10/24

  10 items of Media coverage

  Press/Media

• FDA Clears Software for Enhancing CCTA Assessment of Atherosclerosis

  Ahmadi, A.

  1/10/24

  1 item of Media coverage

  Press/Media

• FDA Grants 510(k) Clearance to PlaqueIQ Imaging Analysis Software; Elucid has received 510(k) clearance for its PlaqueIQ™ imaging analysis software to help physicians diagnose cardiovascular disease.

  Ahmadi, A.

  1/10/24

  2 items of Media coverage

  Press/Media

• FDA clears software to reduce ‘guesstimation’ when assessing atherosclerotic risk

  Ahmadi, A.

  1/10/24

  1 item of Media coverage

  Press/Media